Imbalance of interleukin‐17‐producing <scp>CD</scp>4 <scp>T</scp> cells/regulatory <scp>T</scp> cells axis occurs in remission stage of patients with hepatitis <scp>B</scp> virus‐related acute‐on‐chronic liver failure

Abstract

ACLF patients in the remission stage had an imbalance of Th17 to Treg cells, which could be used as a prognostic marker to predict disease progression. This imbalance could play a role in the immunopathogenesis of HBV-related ACLF.